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 Abstract 
Background 
Human subcutaneous fat tissue consists of two layers: superficial adipose tissue (SAT) 
and deep adipose tissue (DAT). Some recent reports suggest that a disproportionate 
accumulation of DAT is related to obesity-associated metabolic complications. 
However, the differences in adipocyte function between SAT and DAT are unclear.  
Materials and Methods 
To clarify the differences in human adipocyte characteristics between SAT and DAT, 
human ceiling culture-derived proliferative adipocytes (ccdPAs) were primary cultured 
from SAT and DAT of lean females. Differences in adipogenic differentiation potential 
and sensitivity to exogenous adipogenic factors were examined. Epigenetic modification 
of the CpG island DNA methylation levels of genes related to adipogenesis was 
measured. 
Results  
In histological analyses, the mean adipocyte size in SAT was significantly larger than 
that in DAT (8741  416 vs. 7732  213 μm2, P < 0.05). Primary cultured adipocytes 
from SAT showed significantly greater adipogenesis than did those of DAT. Sensitivity 
to partial adipogenic stimulation was significantly different between ccdPAs of SAT 
and DAT. PPAR-γ protein expression and leptin protein secretion from ccdPAs were 
 significantly higher in SAT than DAT. DNA methylation levels of PPARG were 
significantly lower in ccdPAs of SAT than DAT.  
Conclusion 
Adipocyte size was larger in SAT than DAT in vivo. This is consistent with the findings 
of an in vitro study that, compared with ccdPAs in DAT, ccdPAs in SAT have higher 
adipogenic potential and lower DNA methylation levels of PPARG.  
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 Introduction 
 Subcutaneous tissue is divided into two layers: superficial adipose tissue (SAT) and 
deep adipose tissue (DAT) (7). The superficial fascia is the fibrous membrane 
separating the subcutaneous tissue into these two layers. The two-layer structure of 
human subcutaneous tissue can be recognized easily, especially in the abdomen and 
dorsum (Fig. 1A). SAT has thick fibrous septa and cuboid-shaped fat lobules, whereas 
DAT has thin fibrous septa and flat-shaped fat lobules. Based on anatomical studies, 
these two layers are reported to have different physical functions: SAT protects the 
human body from external compression, whereas DAT functions to stretch or slide the 
skin in response to external force (25). 
 Location-specific functional differences in adipocytes between visceral and 
subcutaneous fat have been well investigated (24). However, physiological functional 
differences between SAT and DAT are poorly understood. Recent studies showed that a 
disproportionate accumulation of DAT, but not SAT, was related to impaired systemic 
metabolism, which is similar to the well-known relationship between visceral fat 
accumulation and metabolic impairment (10, 17, 23, 28, 35). However, little is known 
regarding the association of cellular functional differences between the two layers of 
subcutaneous fat and impaired metabolism.  
  We hypothesized that adipocyte function differs between SAT and DAT. To test this 
hypothesis, we analyzed the cellular functions of human primary cultured adipocytes 
from SAT and DAT.   
  
 Methods 
Ethics 
We obtained human adipose tissue from surplus portions of abdominal flaps obtained 
from metabologically healthy lean Japanese female patients who underwent breast 
reconstructive surgery. Lean was defined as normal body weight (18.5 kg / m
2
 ≤ body 
mass index (BMI) < 25.0 kg / m
2
) according to the definition of the Japan Society for 
the Study of Obesity (38). The study protocol was approved by the Ethics Committee of 
Chiba University School of Medicine (approval number 1510). Written informed 
consent was obtained from the subjects. All studies were performed according to the 
guidelines of the Declaration of Helsinki.  
Microscopic analyses of adipose tissue  
 Full-thickness skin samples including epidermal, dermal, and subcutaneous tissues 
above the muscle fascia of the obliquus externus abdominis muscle were obtained and 
fixed in 20% neutral buffered formalin solution (Wako, Osaka, Japan) for hematoxylin-
eosin (HE), Azan, Masson-Goldner (MG) and Elastica van Gieson (EVG) staining 
analyses. Immunohistochemical staining of fatty acid binding protein-4 (FABP4), which 
is a specific marker of the adipocyte membrane, was also performed on the samples 
after fixation using tissue fixative G-Fix (#STF-01, Genostaff, Tokyo, Japan), which is 
10% neutral buffered formalin containing picric acid. As the primary antibody, anti-
 FABP4 rabbit antibody (#15872-1-AP, Proteintech, Chicago, IL, USA) was used. We 
counted the number of adipocytes / mm
2
 on FABP4-stained images and compared these 
values between SAT and DAT. The mean adipocyte area was calculated under a BZ-
9000 microscope (Keyence, Osaka, Japan) as follows: area of the field of view (μm2) / 
number of adipocytes in the field of view.   
Primary cell culture and adipogenic induction 
First, we prepared human primary cultured ceiling culture-derived proliferative 
adipocytes (ccdPAs) and stromal vascular fraction (SVF)-derived progenitor cells 
(adipose-derived stem cells, ASCs) from SAT and DAT separately according to Kuroda 
et al.(20). Under the ethical approval described above, primary cultured ccdPAs and 
ASCs were harvested from subcutaneous adipose tissue of discarded area of abdominal 
flaps of metabologically healthy lean (18.5 kg / m
2
 ≤ body mass index (BMI) < 25.0 kg 
/ m
2
) Japanese female (age range: 41-50). Briefly, fat tissue was weighed, and 1.0 gram 
tissue was digested with gentle shaking at 100 rpm for 1 hour at 37°C in 3 mL Hank’s 
balanced salt solution (Sigma-Aldrich, St. Louis, MO, USA) containing 2 mg / mL 
collagenase (Wako) and 40 µg / mL gentamicin (Gentacin, Schering-Plough, 
Kenilworth, NJ, USA). This solution was then diluted with 10 mL Dulbecco’s modified 
Eagle’s medium/F12-HAM (DMEM/HAM) (Sigma-Aldrich) supplemented with 20% 
fetal bovine serum (FBS) (SAFC Biosciences, Lenexa, KS, USA) and 40 µg / mL 
 gentamicin, mixed, and centrifuged at 400 × g for 1 minute. The dilution steps were 
repeated four times to collect the floating cell fraction. The floating fraction was filtered 
through a 500-µm mesh (Netwell, Corning , NY, USA) and seeded into flasks filled 
with DMEM/HAM supplemented with 20% FBS and 40 µg / mL gentamicin and then 
incubated at 37°C, 5% CO2  for 7 days. After 7 days of ceiling culture, cells that grew 
on the ceiling surfaces were collected as ccdPAs and seeded into flasks for the 
subsequent steps. The sediment from each centrifugation step was collected and 
cultured as ASCs in DMEM/HAM with 20% FBS and 40 µg / mL gentamicin at 37°C, 
5% CO2 for 7 days. To compare adipocytes between SAT and DAT, four populations of 
cells were cultured: ccdPAs obtained from SAT (CS), ccdPAs obtained from DAT (CD), 
ASCs obtained from SAT (AS) and ASCs obtained from DAT (AD). Each cell type 
harvested was cultured and passaged once a week in DMEM/HAM (Sigma-Aldrich) 
containing 20% FBS (SAFC Biosciences) and 40 μg / mL gentamicin (Schering-
Plough). In each experiment, we used cells cultured 30-60 days after harvest. For 
adipogenic induction, after confirming the confluency of seeded cells (5-7 days from 
seeding), we changed the medium to adipogenic differentiation medium (#PT-8002, 
Lonza, Basel, Switzerland) containing 10% FBS and cultured the cells for 14 days. To 
compare adipogenic induction among the four cell populations (CS, CD, AS, and AD), 
we stained the differentiated cells with Oil Red O (Wako) or BODIPY (Life 
 Technologies, Carlsbad, CA, USA). On BODIPY-stained images, each total droplet 
area (green staining) per field of view (1.6 × 10
6
 μm2) was calculated. These 
microscopic studies were performed using a BZ-9000 microscope with the GFP OP-
66835 filter (excitation wavelength 480 nm, emission wavelength 515 nm; Keyence) 
and were analyzed by the BZ-H2C application (Keyence). 
Partial adipogenic stimulation 
This experiment was designed to compare the effect of partial adipogenic stimulation 
on primary cultured ccdPAs harvested from SAT and DAT (CS and CD, respectively). 
After culturing, according to the protocol described above, cells were partially 
stimulated for adipogenesis. Normal adipogenic differentiation medium (#PT-8002, 
Lonza) contains three important factors for adipogenic induction: insulin, 3-isobutyl-1-
methylxanthine (IBMX), and dexamethasone. For partial adipogenic stimulation, we 
prepared three different media, each containing only two of these three factors (insulin, 
IBMX, or dexamethasone). After 14 days of culture in these media, total RNA was 
extracted using the RNeasy Mini kit (Qiagen, Venlo, Netherlands) and was reverse 
transcribed using the ReverTra Ace qPCR RT Master Mix kit (Toyobo, Osaka, Japan). 
Gene expression levels were compared using quantitative reverse transcription-
polymerase chain reaction (RT-PCR), as described in detail below. 
RT-PCR 
 cDNA synthesized from total RNA using the ReverTra Ace qPCR RT kit (Toyobo) 
was subjected to quantitative RT-PCR amplification using TaqMan Gene Expression 
Master Mix (Life Technologies) and the LightCycler 96 system (Roche Applied Science, 
Basel, Switzerland). mRNA expression levels of peroxisome proliferator-activated 
receptor gamma (PPARG), CCAAT/enhancer binding protein delta (CEBPD) and leptin 
(LEP) were quantified by real-time RT-PCR amplification using specific primers, all 
purchased from Life Technologies. The quantification of each gene was expressed as 
the relative mRNA level after normalization to 18S rRNA. 
Adipogenic differentiation and adipogenic markers 
Primary cultured ccdPAs harvested from SAT and DAT (CS and CD, respectively) 
and primary cultured ASCs harvested from SAT and DAT (AS and AD, respectively) 
were cultured in DMEM/HAM with 20% FBS and 40 μg / mL gentamicin. Two days 
after reaching confluency, the medium was changed to adipogenic differentiation 
medium (#PT-8002, Lonza). As a control, medium without insulin, IBMX, or 
dexamethasone was used. After 14 days of culture in adipogenic differentiation medium, 
total RNA was extracted using the RNeasy Mini kit (Qiagen), and quantitative RT-PCR 
was performed, as described above, to measure PPARG and CEBPD mRNA expression 
levels.  
Western blot analysis of PPAR-γ  
 Cell pellets were derived from the differentiated and non-differentiated four cell 
populations (CS, CD, AS, and AD) after culturing as described above. The pellets were 
lysed in ice-cold radio-immunoprecipitation assay (RIPA) buffer containing protease 
inhibitor cocktail (Sigma-Aldrich) and incubated at 4°C for 30 min. After centrifuging 
twice, the supernatants were collected and measured for protein concentration using the 
BCA Protein Assay Kit (Thermo-Scientific, Waltham, MA, USA), with bovine serum 
albumin (BSA) as the standard. These protein extracts were mixed with sodium dodecyl 
sulfate (SDS) sample buffer, heated at 45°C for 15 min, then cooled on ice immediately. 
A 15-µg protein aliquot from each sample was separated by SDS-polyacrylamide gel 
electrophoresis on a 10% gel (ATTO, Tokyo, Japan) and transferred to a polyvinylidene 
difluoride membrane (Bio-Rad, Hercules, CA, USA). After blocking in Tris-buffered 
saline (TBS) with 0.05% Triton X100 containing 1% BSA (Nacalai, Kyoto, Japan) at 
room temperature for 30 min, the membrane was incubated at 4°C overnight with 
PPAR-γ antibody (#2435S, Rabbit mAb, ×300 dilution; Cell Signaling Technology, 
Beverly, MA, USA). Next, excess antibody was washed away using a solution of TBS 
and 0.05% Tween 20 (TBST), and the membrane was incubated with horseradish 
peroxidase (HRP)-conjugated anti-rabbit IgG antibody (#7074S, ×2,000 dilution; Cell 
Signaling Technology) at room temperature for 2 hours. After washing away the excess 
antibody again, the membrane was incubated with SuperSignal West Pico 
 Chemiluminescent Substrate (Thermo-Scientific) at room temperature for 5 min, and 
the signals were detected using X-ray film. To detect the glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) protein, as the loading control, the membrane was incubated 
with anti-GAPDH (#MCA4739, 0.05 μg / mL; Bio-Rad) and HRP-linked anti-mouse 
IgG antibodies (#7076S, ×2,000 dilution; Cell Signaling Technology). The relative 
densities of the detected protein bands were analyzed using ImageJ software (version 
1.47; National Institutes of Health, Bethesda, MD, USA). 
Enzyme-linked immunosorbent assay (ELISA) 
ELISA was performed to evaluate leptin protein production quantitatively in the eight 
cell populations: differentiated and non-differentiated CS, CD, CS, and AD cells. 
Twenty-four hours after changing to serum-free medium, we analyzed leptin levels in 
the serum-free medium by Quantikine ELISA Kit (R&D Systems, Minneapolis, MN, 
USA), according to the manufacturer’s instructions. Absorbance was read using the 
Spectramax 340 plate reader (Molecular Devices, Sunnyvale, CA, USA), and the data 
were analyzed using Softmax PRO software, version 2.04 (Molecular Devices). 
DNA methylation profiling 
DNA was extracted from undifferentiated CS and CD cells after 14 days incubation in 
DMEM/HAM containing 20% FBS and 40 μg / mL gentamicin using the DNeasy kit 
(Qiagen) in accordance with the manufacturer’s instructions. Genome-wide methylation 
 levels were measured by the HumanMethylation450 BeadChip array (Illumina, San 
Diego, CA, USA) according to standard protocol. Genomic DNA samples (0.5 μg) were 
subjected to bisulfite conversion using the EZ DNA methylation kit (Zymo-Research, 
Irvine, CA, USA). After alkaline denaturation, the samples were subjected to whole-
genome amplification, and the resulting genomic DNA was fragmented and 
resuspended in hybridization buffer. After heat-denaturation, the samples were applied 
to the HumanMethylation450 BeadChip and hybridized for 20 hours. Primer extension 
and fluorochrome staining were performed. We obtained images by iScan (Illumina) 
and analyzed the data using GenomeStudio Methylation Module software (Illumina). 
The methylation ratios for individual CpG sites in each sample were represented as β-
values, ranging from 0 (unmethylated) to 1 (completely methylated). We compared 
mean CpG island β-values among the following genes from the UCSC Genome 
Browser: PPARG, CEBPD, and LEP. CpG sites other than CpG islands, shore, shelf 
and open sea regions, were not considered in this analysis. 
Statistical analysis 
Results are presented as means ± standard deviation. Statistical comparisons between 
groups (CS vs. CD and AS vs. AD) were made by Student’s t-test. In all cases, P values 
< 0.05 were considered to be statistically significant. Analyses were conducted using 
SPSS software (version 13.0J; SPSS, Chicago, IL, USA). 
   
 Results 
Adipocytes of SAT are larger than those of DAT in lean subjects    
Low-power microscopic examination of a HE-stained section demonstrated the two 
layers of the lower lateral region of human abdominal subcutaneous adipose tissue, i.e., 
SAT and DAT (Fig. 1B). The thickness of SAT was larger than that of DAT. The 
superficial fascia, which separates subcutaneous tissue into SAT and DAT, is a multi-
layered structure consisting mostly of collagenous fiber and nuclei, according to Azan, 
MG, and EVG staining analyses (Fig. 1C). It was difficult to identify other components, 
such as elastic or muscle fibers, in the superficial fascia.  
 The numbers of adipocytes per unit area in SAT and DAT were counted on images 
stained with FABP4, a specific marker of the adipocyte membrane (Fig. 1D). The mean 
number of adipocytes per unit area was significantly lower in SAT than DAT (1134  
68 vs. 1280  44 / mm2, P < 0.05). The mean adipocyte size was significantly larger in 
SAT than in DAT (8741  416 vs. 7732  213 μm2, P < 0.05).  
 These results indicate an obvious two-layered structure in the lateral abdominal 
subcutaneous tissue in humans and significant differences in adipocyte size between 
SAT and DAT. There were differences found between SAT and DAT not only in gross 
anatomical structures but also at the cellular level. The larger adipocyte size in SAT 
suggests a difference in adipogenic differentiation potential between the two layers. 
 Primary cultured ccdPAs of SAT have higher adipogenic potential than those of DAT  
 After 7 days of ceiling culture, ccdPAs showed similar morphological characteristics to 
those of ASCs: a fibroblast-like shape with no lipid droplets. We previously reported 
that ccdPAs are quite different from ASCs in cellular characteristics despite similar 
morphological aspects (2). One of the main differences between ccdPAs and ASCs is 
that the former have higher adipogenic potential even after 6 weeks of culture. We 
investigated the difference in adipogenic potential of ccdPAs between SAT and DAT 
(CS and CD, respectively). According to both oil red O and BODIPY staining, 
significantly higher adipogenic potential was observed in ccdPAs of SAT than those of 
DAT (Fig. 2). Adipogenesis in ASCs of SAT also was significantly greater than in DAT 
of ASCs. These results indicate that primary cultured ccdPAs of SAT maintain higher 
adipogenic potential than do those of DAT. 
Sensitivity to partial adipogenic stimulation differs between ccdPAs of SAT and DAT 
 We previously reported significant differences between ccdPAs and ASCs in their 
sensitivity to partial adipogenic stimulation, reflecting differences in cellular function 
(2). Here, we examined differences between SAT and DAT in ccdPAs sensitivity to 
adipogenic differentiation factors and observed significant differences between the two 
tissue layers (Fig. 3). In the absence of insulin, there was no significant difference in 
mRNA expression of PPARG between ccdPAs of SAT and DAT. In contrast, CEBPD 
 mRNA expression was significantly lower in ccdPAs of SAT than those of DAT, 
whereas leptin mRNA expression was significantly higher in SAT ccdPAs. In the 
absence of IBMX, PPARG and LEP mRNA expression levels were significantly higher 
in ccdPAs of SAT compared with DAT; in contrast, CEBPD mRNA expression was 
significantly lower in SAT versus DAT ccdPAs. In the absence of dexamethasone, 
PPARG expression was significantly higher in ccdPAs of SAT than those of DAT, and 
the LEP mRNA expression level was below the detection limit in ccdPAs of both SAT 
and DAT.  
 These results indicate significant differences in cellular sensitivity to adipogenic 
induction factors between ccdPAs of SAT and DAT.  
PPAR-γ expression is higher in ccdPAs of SAT versus DAT  
 PPAR-γ is a master regulator of adipogenic differentiation. Adipogenic differentiation 
medium significantly increased PPARG expression in both ccdPAs and ASCs (Fig. 4A). 
PPARG mRNA expression in ccdPAs of SAT was significantly higher than in those of 
DAT. The PPAR-γ protein level of ccdPAs was also significantly higher in SAT than in 
DAT (Fig. 4B). In contrast, mRNA expression of CEPBD, which is involved in 
adipogenic differentiation, was significantly lower in SAT versus DAT ccdPAs (Fig. 
4C). Leptin secretion was significantly higher from ccdPAs of SAT than those of DAT 
when grown in adipogenic differentiation medium (Fig. 4D).  
  These results indicate that primary cultured human adipocytes of SAT have higher 
PPAR-γ expression potential than those of DAT in response to adipogenic induction.  
PPARG DNA methylation levels are lower in ccdPAs of SAT versus DAT 
Recent studies suggest that epigenetic modification plays an essential role in defining 
cellular differentiation (1, 11). Higher methylation levels in promoter regions, which are 
a form of epigenetic modification, are associated with downregulation of gene 
expression. In most of the CpG islands evaluated within PPARG (9 of 11), the mean 
DNA methylation levels were lower in ccdPAs of SAT than those of DAT. The 
differences were statistically significant for two of these CpG islands, cg04748988 and 
cg18887186. In contrast, 2 of 9 CpG islands of CEBPD, cg18923221 and cg22280940, 
the mean DNA methylation levels were significantly higher in ccdPAs of SAT versus 
DAT. There were no statistically significant differences in the DNA methylation levels 
of LEP CpG islands between ccdPAs of SAT versus DAT.  
 These results indicate significant differences in epigenetic modification of the 
adipogenic genes, PPARG and CEBPD, between SAT and DAT ccdPAs, consistent 
with the mRNA and protein expression results.  
  
 Discussion 
 In this study, we confirmed a difference in adipocyte function between the SAT and 
DAT layers of subcutaneous tissue in lean female subjects. Primary cultured human 
adipocytes from SAT showed significantly higher adipogenic potential compared with 
those of DAT. We also showed lower DNA methylation levels of PPARG in SAT 
versus DAT adipocytes, suggesting that PPAR-γ is more likely to be expressed in 
adipocytes of SAT compared with DAT.  
The two layers of subcutaneous tissue in mammals, SAT and DAT, which are separated 
by the superficial fascia, are easily distinguishable with various imaging modalities (9, 
10, 13, 25). Our histological study also showed the obvious structural findings that 
subcutaneous adipose tissue is divided by multi-layered superficial fascia consisting of 
collagen fiber and nuclei. Regarding the physical properties, Nakajima et al. reported 
that SAT is the protective adipofascial system and DAT the lubricant adipofascial 
system (25). However, little is known about the cellular functional differences between 
SAT and DAT. Our study is the first to verify differences in cellular function between 
SAT and DAT using primary cultured human adipocytes. 
 Our histological study of subcutaneous tissue from lean subjects showed greater SAT 
than DAT thickness. In plastic surgery, from various skin surgical experiences in lean 
subjects, subcutaneous tissue has been found to consist mainly of SAT rather than DAT. 
 On the contrary, liposuction in obese subjects is performed on DAT rather than SAT 
because of the greater abundance of DAT (8, 21). This is supported by 3-Tesla magnetic 
resonance imaging studies that showed a steady increase in the proportion of DAT and a 
decrease in the proportion of SAT with increasing obesity (28). Our results suggest that 
in normal metabolic lean subjects, SAT adipocytes are more likely to be mature 
compared with DAT adipocytes.   
 Our histological study on the subcutaneous adipose tissue of lean subjects showed that 
the mean adipocyte size in SAT was larger than that in DAT. This is consistent with 
other reports (4, 5, 23, 34). Marinou et al. reported smaller adipocyte sizes in DAT of 
lean subjects, but equal adipocyte sizes between SAT and DAT of obese subjects (23). 
Wan et al. reported that the difference in size of adipocytes between SAT and DAT 
exists not only in the trunk but also in the face (37). However, it is unclear why 
adipocytes are larger in SAT than DAT. Our results provided a link between adipogenic 
potential in vitro and adipocyte size in vivo. Our finding that adipocytes of SAT have 
higher adipogenic potential than those of DAT due to lower DNA methylation levels of 
the PPARG promoter may be one explanation for the adipocyte size difference between 
SAT and DAT in vivo. 
 Differences in adipocyte function are also shown by the differences in mRNA 
expression patterns induced by partial adipogenic stimulation. In our previous report 
 regarding differences between ccdPAs and ASCs, the mRNA expression patterns 
induced by the various adipogenic factors suggest differences in cell function (2). 
Similarly, adipocytes of SAT and DAT showed quite different mRNA expression 
patterns induced by variations in culture medium, indicating the existence of substantial 
cellular functional differences between adipocytes of SAT and DAT, suggesting 
differences in receptor status, cell signaling, and transcriptional control.   
 Our study showed that primary cultured adipocytes of SAT have higher PPAR-γ 
protein expression and higher leptin secretion levels than those of DAT. Recent studies 
have indicated a relationship between disproportionate accumulation of DAT and 
impaired systemic metabolism, similar to the well-known relationship between visceral 
fat accumulation and metabolic impairment(10, 17, 23, 28, 35). As an example, we 
previously reported that adipocytes of visceral fat, but not subcutaneous fat, secrete 
TNF-α and exacerbate insulin sensitivity (30). Several reports showed that DAT 
accumulates disproportionally more than does SAT in obese subjects, and the 
proportion of DAT in subcutaneous adipose tissue is a predictor of obesity-associated 
disorders (10, 23, 36). Walker et al. reported that adiponectin protein expression is 
higher in SAT than DAT in lean individuals, similar to our results that primary cultured 
adipocytes of SAT express more PPARG and LEP than do those of DAT (36). Cancello 
et al. reported that in obese individuals, tissue mRNA expression levels of PPARG and 
 adiponectin in subcutaneous adipose tissue were significantly lower in DAT, whereas 
those of HIF-1α and TNF-α were significantly higher (5). 
 Analysis of the differences in adipocyte function between SAT and DAT is also import 
for adipocyte transplantation. We previously reported that PPAR-γ expression 
stimulated by bFGF is important for engraftment and maturation of transplanted 
adipocytes in mice (19). Transplantation of adipocytes was originally used as a method 
of tissue augmentation. Currently, the application of adipocyte transplantation has 
broadened. Adipocyte transplantation has recently been used to facilitate the wound 
healing process, to ameliorate scar tissue quality, and as a vehicle for gene therapy, a 
subject of focus for us (6, 16, 20) . We have published several previous reports on a 
gene therapy model using transfected adipocytes as a vehicle (14, 15, 18). In such 
models, the risk of malignancy-associated mutation of the transfected cells is a major 
problem. Shimizu et al. reported that cells with higher adipogenic potential show less 
susceptibility to malignancy-associated mutations (31). Based on our results that 
adipocytes of SAT have higher adipogenic potential than those of DAT, the former are 
preferable to the latter for adipocyte transplantation. However, generally, liposuction of 
abdominal subcutaneous tissue is performed on DAT rather than SAT because of its 
abundance and looseness (8). Further investigation is required to conclude whether SAT 
versus DAT is preferable as a donor site for adipocyte transplantation. 
  Epigenetic control of gene expression is a key regulator of cellular differentiation (11). 
In our study, the DNA methylation level of the promotor of the adipogenic master 
regulator gene PPARG was lower in adipocytes of SAT than those of DAT. Our result is 
consistent with a previous animal study showing that adipose tissue development is 
regulated by epigenetic DNA methylation of PPARG (32). In contrast, in our study, 
adipocytes of SAT showed significantly higher DNA methylation levels of CEBPD, 
another gene related to adipogenesis, than did those of DAT. CEBP-δ, in coordination 
with CEBP-β, induces PPAR-γ expression (12, 26). However, animal experiments have 
shown that PPAR-γ is indispensable for adipogenesis, whereas CEPB-δ is not 
necessarily indispensable, in that mice lacking CEBPD can exhibit adipogenesis and 
normal PPAR-γ expression (3, 27, 33). The DNA methylation level of LEP was not 
different between SAT and DAT adipocytes, although leptin secretion was significantly 
higher in the former. We believe that the higher leptin secretion from SAT adipocytes is 
a result of their more advanced maturation due to higher PPAR-γ expression. Further 
investigation is required to clarify why and when differences arise in DNA methylation 
levels of adipocytes between SAT and DAT. 
 Several reports have shown that the degree of fat accumulation is higher in DAT than 
SAT in obesity. However, it is controversial whether the surrounding environment of 
adipocytes or the intrinsic nature of adipocytes is the cause of differences in fat 
 accumulation (17). Our results support differences in the intrinsic nature of adipocytes 
between SAT and DAT. However, Boulet et al. reported that although SAT showed 
higher LEP mRNA expression levels, the cause is not intrinsic adipocyte properties but 
rather T lymphocyte accumulation (4). In contrast, Shultz et al. showed that differences 
in adipocyte function, based on epigenetic modifications, form as early as the fetal stage 
(29). Li et al. also showed, in a porcine study, intrinsic functional differences between 
the two tissue layers due to significant differences in DNA methylation levels of genes 
involved in cytokine production (22). Our research using primary cultured adipocytes 
from humans also supports the existence of intrinsic adipocyte functional differences 
between SAT and DAT.        
    In summary, we showed that human adipocytes of SAT are larger than those of DAT 
in vivo, and that primary cultured adipocytes harvested from SAT have higher 
adipogenic potential than those harvested from DAT. This is consistent with our results 
that DNA methylation levels of PPARG were lower in primary cultured adipocytes of 
SAT versus DAT. Our results provide a theoretical basis for physiological differences 
between SAT and DAT. 
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Table. 1 
Gene Probe ID chr Map info. β value          
CS ± sd CD ±  sd p value   
PPARG 
cg04632671 3 12329826 0.005 ± 0.003 0.004 ± 0.003 0.427 
cg04748988 3 12329223 0.028 ± 0.003 0.033 ± 0.003 0.001 * 
cg06573644 3 12329101 0.047 ± 0.012 0.054 ± 0.007 0.207 
cg07556134 3 12330263 0.011 ± 0.005 0.009 ± 0.007 0.369 
cg09405169 3 12329745 0.018 ± 0.002 0.020 ± 0.004 0.306 
cg13518792 3 12329590 0.004 ± 0.003 0.011 ± 0.006 0.169 
cg18887186 3 12330332 0.067 ± 0.002 0.077 ± 0.007 0.047 * 
cg21946299 3 12329166 0.078 ± 0.005 0.079 ± 0.007 0.460 
cg23514324 3 12329213 0.065 ± 0.035 0.069 ± 0.019 0.386 
cg26364899 3 12329070 0.042 ± 0.004 0.052 ± 0.009 0.083 
cg27095527 3 12329080 0.035 ± 0.011 0.038 ± 0.005 0.407 
CEBPD 
cg04239843 8 48649767 0.057 ± 0.005 0.059 ± 0.003 0.162 
cg06734962 8 48650989 0.059 ± 0.006 0.061 ± 0.005 0.273 
cg13402155 8 48650705 0.050 ± 0.001 0.055 ± 0.005 0.188 
cg16241714 8 48650511 0.008 ± 0.004 0.005 ± 0.001 0.207 
cg17194240 8 48651122 0.006 ± 0.002 0.006 ± 0.005 0.486 
cg18923221 8 48650727 0.063 ± 0.005 0.055 ± 0.004 0.000 * 
cg21315018 8 48651635 0.037 ± 0.003 0.041 ± 0.002 0.155 
cg22280940 8 48650745 0.008 ± 0.002 0.002 ± 0.001 0.012 * 
cg23495695 8 48651311 0.010 ± 0.004 0.015 ± 0.002 0.066 
LEP 
cg00840332 7 127881269 0.046 ± 0.015 0.044 ± 0.022 0.479 
cg07464571 7 127881001 0.137 ± 0.045 0.154 ± 0.037 0.183 
cg12782180 7 127880932 0.154 ± 0.053 0.152 ± 0.042 0.491 
cg13381984 7 127881344 0.120 ± 0.008 0.145 ± 0.027 0.187 
cg19594666 7 127881280 0.108 ± 0.030 0.133 ± 0.040 0.318 
cg26814075 7 127881298 0.186 ± 0.016 0.175 ± 0.012 0.223 
 Figure captions 
 
Fig. 1. Macroscopic, radiographic and microscopic observations of the two layers of human 
subcutaneous tissue. (A) The superficial fascia anatomically separates subcutaneous tissue into 
superficial adipose tissue (SAT) and deep adipose tissue (DAT). SAT has thick fibrous septa and 
cuboid-shaped fat lobules, whereas DAT has thin fibrous septa and flat-shaped fat lobules. A 
magnetic resonance image also shows the structure of the tissue clearly. (B) Hematoxylin-eosin 
(HE) staining shows the gross anatomical structure of subcutaneous tissue. SAT was confirmed 
to be thicker than DAT and superficial fascia to be a multi-layered structure. (C) Azan, 
Masson-Goldner (MG) and Elastica van Gieson (EVG) staining accentuate the superficial fascia 
consisting of collagenous fibers and nuclei. (D) The number of cells / mm
2
 and cell area in each 
adipose tissue layer, using fatty acid binding protein 4 (FABP4) staining, were compared. n = 3.  
*P < 0.05. 
 
Fig. 2. Microscopic comparison of the adipogenic status among four populations of primary 
cultured adipocytes: CS: ceiling culture-derived proliferative adipocytes (ccdPAs) obtained from 
SAT; CD: ccdPAs obtained from DAT; AS: adipose-derived stem cells (ASCs) obtained from 
SAT; AD: ASCs obtained from DAT. (A) After incubation with normal medium and 
confirmation of confluency, the cells were cultured for 14 days in adipogenic differentiation 
medium. Oil Red O and BODIPY staining was then performed. (B) In BODIPY-stained images 
 of the four cell types, the stained areas, i.e. areas of droplets per field of view (1.6 × 10
6
 μm2), 
were calculated. n = 3. *P < 0.05. 
 
Fig. 3. Evaluation of cellular differentiation in response to partial adipogenic stimulation in the 
CS and CD cell populations. Three variations of the original medium were used in which one 
factor each of insulin (INS), 3-isobutyl-1-methylxanthine (IBMX) or dexamethasone (DEX), 
was removed. Gene expression of the following adipogenic markers was compared by RT-PCR: 
peroxisome proliferator-activated receptor γ (PPARG) (A), CCAAT/enhancer binding protein δ 
(CEBPD) (B) and LEP (C). n = 3. *P < 0.05. 
 
Fig. 4. Evaluation of the expression levels of adipogenesis-related genes and proteins in 
response to adipogenic differentiation stimulation in four populations of cells with or without 
adipogenic induction (AI): CS, CD, AS, and AD. (A) The mRNA expression levels of PPARG 
were measured and compared by RT-PCR. (B) Western blot bands representing PPAR-γ were 
seen in each of the differentiated cell populations. The protein expression level was expressed as 
the band density relative to that of glyceraldehyde-3-phosphate dehydrogenase (GAPDH). (C) 
The mRNA expression levels for CEBPD were measured by RT-PCR. (D) ELISA was 
performed to evaluate leptin protein secretion. n = 3. *P < 0.05. 
 
Table 1. CpG island methylation of genes related to adipogenesis. Genome-wide methylation 
 levels of two populations of adipocytes were measured: CS and CD. The beta-values (mean ± 
SD) of each CpG island within the adipogenesis-related genes PPARG, CEBPD and LEP were 
compared. Probe ID: the CpG locus ID identified by Illumina. chr: chromosome number from 
genome reference consortium human build 37 (GRCh37). Map info: the base coordinate from 
GRCh37. n = 3. *P < 0.05. 
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